Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health

Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health

Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability in young adults. It has effects at different levels: physical, emotional, psychological, cognitive and social, with a great variety of signs and symptoms. In particular, spasticity contributes to reducing the m...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Silvia Ciotti, Mary Micheli, Antonella Cometa, Claudia De Carlo, Giancarlo Martini, Andrea Marona, Laura Filippetti, Diego Carducci, Silvano Baratta, Mauro Zampolini, Francesco Corea
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: SMC MEDIA SRL 2021-10-01
Cyfres:European Journal of Case Reports in Internal Medicine
Pynciau:
multiple sclerosis
icf
neurorehabilitation
delta-9-tetrahydrocannabinol/cannabidiol
Mynediad Ar-lein:https://www.ejcrim.com/index.php/EJCRIM/article/view/2298

Rhyngrwyd

https://www.ejcrim.com/index.php/EJCRIM/article/view/2298

Eitemau Tebyg